Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number ADA570693
Title Traditional Herbal Medicine Use Associated with Liver Fibrosis in Rural Rakai, Uganda.
Publication Date Nov 2012
Media Count 10p
Personal Author B. J. Auerbach C. Kukunda-Byobona C. Merry M. Lamorde S. J. Reynolds
Abstract Traditional herbal medicines are commonly used for HIV/ AIDS and other health conditions in Uganda and sub-Saharan Africa, often in parallel with programs that provide antiretroviral therapy (ART). In the 1990's an estimated 80% of Ugandans living in rural villages used traditional healers for primary health care. A study of 137 HIV-infected Ugandans receiving ART found that 60% used herbs concurrently with ART. In Uganda traditional herbal medicines are usually boiled extracts of herbs taken orally. Some potentially hepatotoxic traditional herbal medicines used in Uganda and sub-Saharan Africa include Hoodia gordonia, Phytolacca dioica, and herbs from the Asteraceae family. Little is known about the hepatotoxicity of other commonly used herbs or the contribution of herbs to the burden of liver fibrosis and hepatocellular carcinoma in sub-Saharan Africa, including when used concomitantly with ART. Data on the specific types of herbs taken by HIV-infected persons in Uganda is limited, as is information about their components, side effects, toxicities, and ART interactions. In Rakai, Uganda, liver toxicity associated with herbal medicine may be of particular concern given the high prevalence of significant liver disease (17%) among HIV- infected persons in Rakai recently identified by transient elastography (FibroScanH Echosense, Paris, France). In the aforementioned study reported herbal medicine use was associated with a two-fold increased risk of significant liver disease, defined as a transient elastography score equivalent to METAVIR liver fibrosis stage 2 (portal fibrosis with few septa) or greater. The study presented here follows up on this prior investigation with an in-depth analysis of the herbs used by study participants and their relation to liver fibrosis.
Keywords Adjprr(Adjusted prevalence risk ratios)
Art(Antiretroviral therapy)
Elastography
Fibroscans
Fibrosis
Human immunodeficiency viruses
Liver diseases
Liver fibrosis
Medicine
Pharmacology
Plants(Botany)
Ratios
Subsaharan africa
Toxicity
Traditional herbal medicines
Uganda
Villages


 
Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author Harvard Medical School, Boston, MA.
Document Type Journal article
Title Note Journal article.
NTIS Issue Number 1315
Contract Number DAMD17-98-2-8007 R01-AI-16078

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader